Executing Effective Commercialisation Strategies: E.U. Vs U.S.

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/2b/35/38/2b3538c7-338a-f4b9-76bc-f3a1db3fb287/mza_9747440335057467958.jpg/600x600bb.jpg

The Venari Growth Podcast

Venari Partners

18 episodes

1 day ago

In this series our consultants speak to business leaders on how they are uncovering the pathways to profitable and strategic growth.

Careers

Business

RSS

All content for The Venari Growth Podcast is the property of Venari Partners and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

In this series our consultants speak to business leaders on how they are uncovering the pathways to profitable and strategic growth.

Careers

Business

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/42588354/42588354-1733317329845-9ae985b760739.jpg

Executing Effective Commercialisation Strategies: E.U. Vs U.S. | Kirsten Detrick

The Venari Growth Podcast

14 minutes 13 seconds

2 years ago

Executing Effective Commercialisation Strategies: E.U. Vs U.S. | Kirsten Detrick

With over 30 years’ experience in launching and leading multi-billion-dollar blockbuster drug launches, Kirsten Detrick is more than qualified to discuss what is needed for successful commercial strategies in biopharma. She was most recently CCO at Endpoint Health, and remains sought-after by biotechs preparing for commercialisation. Kirsten spoke to our Life Sciences Commercial Consultant, Joe Knight, for the Venari Podcast Chief Commercial Officer series. Listen to their conversation which touched on Kirsten’s journey towards becoming a CCO, commercialisation and talent strategies!